Despite concerns about the quality of Medicare Advantage encounter data, it’s long past time to make that information available to researchers who want to study the ever-growing privatized Medicare ...

Two of the biggest medical journals in the world have taken up some big picture mobile health questions this week: How are patients to know which medical apps work out of the sea of available options, ...

Precision medicine’s got its legion of believers, but there’s a healthy dose of skepticism in the medical community – as outlined in a balanced new JAMA piece, “Precision Medicine: The Future or ...

Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, and two colleagues laid out how the agency is working to use real-world data to address the evidence gap between clinical ...

As any new parent can attest, one of the scarier parts of bringing home a new baby is the threat of sudden infant death syndrome. So it's no surprise that parents today are spending upward of $250, ...

The answer is that the blog post at JAMA received more attention. It’s not surprising, actually. The JAMA piece was in sync with the media; it was about the State of the Union Address, which had ...

While the U.S. healthcare industry has made strides in lowering the number of adverse events, many problems still remain. And one thing could be holding the industry back from achieving the goal of ...

Researchers at the University of California, San Francisco Center for Excellence in Primary Care, as lead authors on commentaries in two of the nation’s leading medical journals this week, call for a ...

How to properly allocate a COVID-19 vaccine that will be in scarce supply when it is approved has become a major question. One potential answer in a new opinion piece in the Journal of the American ...

Gay marriage laws and court rulings against sexual-orientation discrimination are all signs that it’s time for the federal government to change its blood-donor policy for gay and bisexual men, authors ...